nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Temozolomide—melanoma	0.28	0.576	CbGbCtD
Sufentanil—CYP3A4—Vemurafenib—melanoma	0.153	0.316	CbGbCtD
Sufentanil—CYP3A4—Docetaxel—melanoma	0.0527	0.108	CbGbCtD
Sufentanil—Injection site pain—Carmustine—melanoma	0.00513	0.0371	CcSEcCtD
Sufentanil—Urinary incontinence—Carmustine—melanoma	0.00404	0.0292	CcSEcCtD
Sufentanil—Urinary incontinence—Temozolomide—melanoma	0.00391	0.0282	CcSEcCtD
Sufentanil—Chills—Vemurafenib—melanoma	0.00357	0.0258	CcSEcCtD
Sufentanil—Erythema—Vemurafenib—melanoma	0.00346	0.025	CcSEcCtD
Sufentanil—Bronchospasm—Bleomycin—melanoma	0.00296	0.0214	CcSEcCtD
Sufentanil—Anaphylactic shock—Vemurafenib—melanoma	0.00283	0.0204	CcSEcCtD
Sufentanil—Hypotension—Vemurafenib—melanoma	0.00264	0.0191	CcSEcCtD
Sufentanil—Body temperature increased—Vemurafenib—melanoma	0.00223	0.0161	CcSEcCtD
Sufentanil—Chills—Bleomycin—melanoma	0.00216	0.0156	CcSEcCtD
Sufentanil—Erythema—Bleomycin—melanoma	0.0021	0.0151	CcSEcCtD
Sufentanil—Hypersensitivity—Vemurafenib—melanoma	0.00208	0.015	CcSEcCtD
Sufentanil—Alfentanil—ALB—melanoma	0.00203	0.434	CrCbGaD
Sufentanil—Chills—Dactinomycin—melanoma	0.00202	0.0146	CcSEcCtD
Sufentanil—Urinary tract disorder—Temozolomide—melanoma	0.00201	0.0145	CcSEcCtD
Sufentanil—Pruritus—Vemurafenib—melanoma	0.002	0.0144	CcSEcCtD
Sufentanil—Urethral disorder—Temozolomide—melanoma	0.00199	0.0144	CcSEcCtD
Sufentanil—Erythema—Dactinomycin—melanoma	0.00196	0.0141	CcSEcCtD
Sufentanil—Alfentanil—ABCB1—melanoma	0.00193	0.414	CrCbGaD
Sufentanil—Arrhythmia—Carmustine—melanoma	0.00188	0.0136	CcSEcCtD
Sufentanil—Dizziness—Vemurafenib—melanoma	0.00187	0.0135	CcSEcCtD
Sufentanil—Erythema—Carmustine—melanoma	0.00183	0.0132	CcSEcCtD
Sufentanil—Chills—Temozolomide—melanoma	0.00182	0.0132	CcSEcCtD
Sufentanil—Vomiting—Vemurafenib—melanoma	0.0018	0.013	CcSEcCtD
Sufentanil—Rash—Vemurafenib—melanoma	0.00178	0.0129	CcSEcCtD
Sufentanil—Dermatitis—Vemurafenib—melanoma	0.00178	0.0129	CcSEcCtD
Sufentanil—Headache—Vemurafenib—melanoma	0.00177	0.0128	CcSEcCtD
Sufentanil—Erythema—Temozolomide—melanoma	0.00177	0.0128	CcSEcCtD
Sufentanil—Confusional state—Bleomycin—melanoma	0.00173	0.0125	CcSEcCtD
Sufentanil—Anaphylactic shock—Bleomycin—melanoma	0.00171	0.0124	CcSEcCtD
Sufentanil—Nausea—Vemurafenib—melanoma	0.00168	0.0121	CcSEcCtD
Sufentanil—Bronchospasm—Docetaxel—melanoma	0.00166	0.012	CcSEcCtD
Sufentanil—Hypotension—Bleomycin—melanoma	0.0016	0.0116	CcSEcCtD
Sufentanil—Hypertension—Carmustine—melanoma	0.00158	0.0114	CcSEcCtD
Sufentanil—Hypertension—Temozolomide—melanoma	0.00153	0.011	CcSEcCtD
Sufentanil—Confusional state—Carmustine—melanoma	0.00151	0.0109	CcSEcCtD
Sufentanil—Tachycardia—Carmustine—melanoma	0.00146	0.0105	CcSEcCtD
Sufentanil—Confusional state—Temozolomide—melanoma	0.00146	0.0105	CcSEcCtD
Sufentanil—Anaphylactic shock—Temozolomide—melanoma	0.00144	0.0104	CcSEcCtD
Sufentanil—Feeling abnormal—Bleomycin—melanoma	0.00141	0.0102	CcSEcCtD
Sufentanil—Hypotension—Carmustine—melanoma	0.0014	0.0101	CcSEcCtD
Sufentanil—Body temperature increased—Bleomycin—melanoma	0.00135	0.00977	CcSEcCtD
Sufentanil—Urinary tract disorder—Docetaxel—melanoma	0.00133	0.00964	CcSEcCtD
Sufentanil—Somnolence—Carmustine—melanoma	0.00133	0.00959	CcSEcCtD
Sufentanil—Urethral disorder—Docetaxel—melanoma	0.00132	0.00957	CcSEcCtD
Sufentanil—Feeling abnormal—Dactinomycin—melanoma	0.00132	0.0095	CcSEcCtD
Sufentanil—Somnolence—Temozolomide—melanoma	0.00128	0.00927	CcSEcCtD
Sufentanil—Body temperature increased—Dactinomycin—melanoma	0.00126	0.00912	CcSEcCtD
Sufentanil—Hypersensitivity—Bleomycin—melanoma	0.00126	0.00911	CcSEcCtD
Sufentanil—Feeling abnormal—Carmustine—melanoma	0.00123	0.00889	CcSEcCtD
Sufentanil—Chills—Docetaxel—melanoma	0.00121	0.00876	CcSEcCtD
Sufentanil—Pruritus—Bleomycin—melanoma	0.00121	0.00875	CcSEcCtD
Sufentanil—Arrhythmia—Docetaxel—melanoma	0.00121	0.00872	CcSEcCtD
Sufentanil—Feeling abnormal—Temozolomide—melanoma	0.00119	0.00859	CcSEcCtD
Sufentanil—Body temperature increased—Carmustine—melanoma	0.00118	0.00853	CcSEcCtD
Sufentanil—Erythema—Docetaxel—melanoma	0.00118	0.0085	CcSEcCtD
Sufentanil—Hypersensitivity—Dactinomycin—melanoma	0.00118	0.0085	CcSEcCtD
Sufentanil—Body temperature increased—Temozolomide—melanoma	0.00114	0.00824	CcSEcCtD
Sufentanil—Hypersensitivity—Carmustine—melanoma	0.0011	0.00795	CcSEcCtD
Sufentanil—Vomiting—Bleomycin—melanoma	0.00109	0.00786	CcSEcCtD
Sufentanil—Rash—Bleomycin—melanoma	0.00108	0.0078	CcSEcCtD
Sufentanil—Dermatitis—Bleomycin—melanoma	0.00108	0.00779	CcSEcCtD
Sufentanil—Hypersensitivity—Temozolomide—melanoma	0.00106	0.00768	CcSEcCtD
Sufentanil—Pruritus—Temozolomide—melanoma	0.00102	0.00738	CcSEcCtD
Sufentanil—Nausea—Bleomycin—melanoma	0.00102	0.00734	CcSEcCtD
Sufentanil—Hypertension—Docetaxel—melanoma	0.00102	0.00734	CcSEcCtD
Sufentanil—Vomiting—Dactinomycin—melanoma	0.00102	0.00733	CcSEcCtD
Sufentanil—Rash—Dactinomycin—melanoma	0.00101	0.00727	CcSEcCtD
Sufentanil—Dizziness—Carmustine—melanoma	0.000988	0.00714	CcSEcCtD
Sufentanil—Confusional state—Docetaxel—melanoma	0.000968	0.00699	CcSEcCtD
Sufentanil—Anaphylactic shock—Docetaxel—melanoma	0.00096	0.00694	CcSEcCtD
Sufentanil—Dizziness—Temozolomide—melanoma	0.000955	0.0069	CcSEcCtD
Sufentanil—Vomiting—Carmustine—melanoma	0.00095	0.00686	CcSEcCtD
Sufentanil—Nausea—Dactinomycin—melanoma	0.000948	0.00685	CcSEcCtD
Sufentanil—Rash—Carmustine—melanoma	0.000942	0.0068	CcSEcCtD
Sufentanil—Dermatitis—Carmustine—melanoma	0.000941	0.0068	CcSEcCtD
Sufentanil—Tachycardia—Docetaxel—melanoma	0.000937	0.00677	CcSEcCtD
Sufentanil—Headache—Carmustine—melanoma	0.000936	0.00676	CcSEcCtD
Sufentanil—Vomiting—Temozolomide—melanoma	0.000918	0.00663	CcSEcCtD
Sufentanil—Rash—Temozolomide—melanoma	0.00091	0.00658	CcSEcCtD
Sufentanil—Dermatitis—Temozolomide—melanoma	0.00091	0.00657	CcSEcCtD
Sufentanil—Headache—Temozolomide—melanoma	0.000905	0.00653	CcSEcCtD
Sufentanil—Hypotension—Docetaxel—melanoma	0.000897	0.00648	CcSEcCtD
Sufentanil—Nausea—Carmustine—melanoma	0.000888	0.00641	CcSEcCtD
Sufentanil—Nausea—Temozolomide—melanoma	0.000858	0.00619	CcSEcCtD
Sufentanil—Somnolence—Docetaxel—melanoma	0.000854	0.00617	CcSEcCtD
Sufentanil—Feeling abnormal—Docetaxel—melanoma	0.000791	0.00572	CcSEcCtD
Sufentanil—Body temperature increased—Docetaxel—melanoma	0.000759	0.00548	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—melanoma	0.000708	0.152	CrCbGaD
Sufentanil—Hypersensitivity—Docetaxel—melanoma	0.000707	0.00511	CcSEcCtD
Sufentanil—Pruritus—Docetaxel—melanoma	0.000679	0.00491	CcSEcCtD
Sufentanil—Dizziness—Docetaxel—melanoma	0.000635	0.00459	CcSEcCtD
Sufentanil—Vomiting—Docetaxel—melanoma	0.000611	0.00441	CcSEcCtD
Sufentanil—Rash—Docetaxel—melanoma	0.000605	0.00437	CcSEcCtD
Sufentanil—Dermatitis—Docetaxel—melanoma	0.000605	0.00437	CcSEcCtD
Sufentanil—Headache—Docetaxel—melanoma	0.000602	0.00434	CcSEcCtD
Sufentanil—Nausea—Docetaxel—melanoma	0.00057	0.00412	CcSEcCtD
Sufentanil—OPRD1—GPCR downstream signaling—IL2—melanoma	0.000116	0.000314	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CD—melanoma	0.000116	0.000312	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—E2F1—melanoma	0.000116	0.000312	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GNAQ—melanoma	0.000116	0.000312	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CB—melanoma	0.000115	0.00031	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PDGFRA—melanoma	0.000114	0.000309	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ITGB3—melanoma	0.000113	0.000305	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PRKCA—melanoma	0.000113	0.000305	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB4—melanoma	0.000111	0.000301	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CG—melanoma	0.000111	0.0003	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CB—melanoma	0.000111	0.0003	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SPP1—melanoma	0.000111	0.0003	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAP2K2—melanoma	0.000111	0.000299	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—melanoma	0.000111	0.000298	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN2B—melanoma	0.00011	0.000298	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SYK—melanoma	0.000109	0.000293	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	0.000108	0.000291	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD86—melanoma	0.000107	0.000288	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—melanoma	0.000107	0.000288	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ITGAV—melanoma	0.000107	0.000288	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT3—melanoma	0.000107	0.000288	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NGFR—melanoma	0.000107	0.000288	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDN1—melanoma	0.000106	0.000286	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL2—melanoma	0.000106	0.000285	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TERT—melanoma	0.000105	0.000284	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAC1—melanoma	0.000105	0.000283	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CSF2—melanoma	0.000104	0.000279	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF1—melanoma	0.000104	0.000279	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2—melanoma	0.000102	0.000275	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—E2F1—melanoma	0.000101	0.000273	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CB—melanoma	0.000101	0.000272	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HIF1A—melanoma	0.000101	0.000272	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PDGFRA—melanoma	0.0001	0.000271	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCA—melanoma	9.93e-05	0.000268	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ITGB3—melanoma	9.93e-05	0.000268	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOCS1—melanoma	9.87e-05	0.000266	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAP2K1—melanoma	9.85e-05	0.000266	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—S100B—melanoma	9.85e-05	0.000266	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CD—melanoma	9.78e-05	0.000264	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SPP1—melanoma	9.74e-05	0.000263	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAP2K2—melanoma	9.71e-05	0.000262	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—melanoma	9.7e-05	0.000262	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—melanoma	9.63e-05	0.00026	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCB4—melanoma	9.62e-05	0.000259	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB4—melanoma	9.42e-05	0.000254	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	9.39e-05	0.000253	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN2B—melanoma	9.33e-05	0.000252	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FN1—melanoma	9.27e-05	0.00025	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—melanoma	9.27e-05	0.00025	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TERT—melanoma	9.23e-05	0.000249	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAC1—melanoma	9.21e-05	0.000248	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOTCH1—melanoma	9.07e-05	0.000245	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC6A11—melanoma	9.04e-05	0.000244	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIP4K2A—melanoma	9.04e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD86—melanoma	9.03e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—melanoma	9.02e-05	0.000243	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—melanoma	8.96e-05	0.000242	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CD80—melanoma	8.89e-05	0.00024	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APC—melanoma	8.87e-05	0.000239	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—melanoma	8.87e-05	0.000239	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KIT—melanoma	8.87e-05	0.000239	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—NRAS—melanoma	8.87e-05	0.000239	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—melanoma	8.83e-05	0.000238	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTAP—melanoma	8.79e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGF—melanoma	8.77e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CSF2—melanoma	8.75e-05	0.000236	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF1—melanoma	8.75e-05	0.000236	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—melanoma	8.62e-05	0.000233	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—E2F1—melanoma	8.57e-05	0.000231	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—melanoma	8.53e-05	0.00023	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK3—melanoma	8.5e-05	0.000229	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFRA—melanoma	8.48e-05	0.000229	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—melanoma	8.44e-05	0.000228	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCA—melanoma	8.39e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ITGB3—melanoma	8.39e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BRAF—melanoma	8.34e-05	0.000225	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SPP1—melanoma	8.23e-05	0.000222	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAP2K2—melanoma	8.2e-05	0.000221	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—melanoma	8.19e-05	0.000221	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FN1—melanoma	8.13e-05	0.000219	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—melanoma	8.12e-05	0.000219	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK1—melanoma	8.08e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—melanoma	8.08e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH1—melanoma	7.95e-05	0.000215	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAP2K1—melanoma	7.85e-05	0.000212	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LUM—melanoma	7.84e-05	0.000211	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PHGDH—melanoma	7.84e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—melanoma	7.83e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—melanoma	7.8e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—melanoma	7.8e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD80—melanoma	7.79e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAC1—melanoma	7.78e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIT—melanoma	7.78e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—melanoma	7.78e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APC—melanoma	7.78e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—NRAS—melanoma	7.78e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	7.72e-05	0.000208	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGF—melanoma	7.69e-05	0.000207	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPSE—melanoma	7.69e-05	0.000207	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—melanoma	7.63e-05	0.000206	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CUBN—melanoma	7.55e-05	0.000204	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF2—melanoma	7.47e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—melanoma	7.46e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK3—melanoma	7.45e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BRAF—melanoma	7.31e-05	0.000197	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SDHD—melanoma	7.29e-05	0.000197	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CSPG4—melanoma	7.29e-05	0.000197	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BSG—melanoma	7.29e-05	0.000197	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—melanoma	7.14e-05	0.000192	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—melanoma	7.12e-05	0.000192	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK1—melanoma	7.09e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—melanoma	7.09e-05	0.000191	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPAM—melanoma	7.06e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—melanoma	7.01e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MDM2—melanoma	6.99e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB2—melanoma	6.89e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAP2K1—melanoma	6.88e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FN1—melanoma	6.87e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—melanoma	6.84e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—melanoma	6.8e-05	0.000183	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	6.77e-05	0.000183	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH1—melanoma	6.72e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—melanoma	6.69e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD80—melanoma	6.59e-05	0.000178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APC—melanoma	6.57e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—melanoma	6.57e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIT—melanoma	6.57e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—NRAS—melanoma	6.57e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF2—melanoma	6.55e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—melanoma	6.53e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGF—melanoma	6.5e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRAS—melanoma	6.49e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1B—melanoma	6.38e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—melanoma	6.31e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK3—melanoma	6.3e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—melanoma	6.25e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—melanoma	6.24e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—melanoma	6.21e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BRAF—melanoma	6.18e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—melanoma	6.15e-05	0.000166	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MDM2—melanoma	6.13e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—melanoma	6.09e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB2—melanoma	6.04e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CTNNB1—melanoma	6.03e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—melanoma	6.02e-05	0.000162	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G6—melanoma	6e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK1—melanoma	5.99e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—melanoma	5.99e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—melanoma	5.96e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—melanoma	5.91e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1A—melanoma	5.89e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—melanoma	5.87e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKB1—melanoma	5.85e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAP2K1—melanoma	5.82e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—melanoma	5.78e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—melanoma	5.73e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—melanoma	5.73e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	5.72e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRAS—melanoma	5.69e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—melanoma	5.66e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1B—melanoma	5.59e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF2—melanoma	5.53e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—melanoma	5.53e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—melanoma	5.48e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—melanoma	5.47e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—melanoma	5.45e-05	0.000147	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—VCAN—melanoma	5.39e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—melanoma	5.34e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—melanoma	5.31e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CTNNB1—melanoma	5.28e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—melanoma	5.25e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NRAS—melanoma	5.24e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—melanoma	5.2e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—melanoma	5.18e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MDM2—melanoma	5.18e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1A—melanoma	5.16e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—melanoma	5.15e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKB1—melanoma	5.13e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB2—melanoma	5.1e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—melanoma	5.04e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—melanoma	5.02e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK3—melanoma	5.02e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—melanoma	4.88e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—melanoma	4.84e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRAS—melanoma	4.81e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK1—melanoma	4.78e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—melanoma	4.77e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1B—melanoma	4.73e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—melanoma	4.68e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—melanoma	4.65e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—melanoma	4.63e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—melanoma	4.63e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—melanoma	4.61e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—melanoma	4.6e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NRAS—melanoma	4.59e-05	0.000124	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP17A1—melanoma	4.55e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—melanoma	4.51e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—melanoma	4.51e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CTNNB1—melanoma	4.47e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK3—melanoma	4.4e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—melanoma	4.38e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1A—melanoma	4.36e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—melanoma	4.35e-05	0.000117	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKB1—melanoma	4.33e-05	0.000117	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GNA11—melanoma	4.29e-05	0.000116	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—melanoma	4.28e-05	0.000115	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—melanoma	4.25e-05	0.000115	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FASN—melanoma	4.2e-05	0.000113	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK1—melanoma	4.19e-05	0.000113	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—melanoma	4.19e-05	0.000113	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—melanoma	4.14e-05	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC5A5—melanoma	4.13e-05	0.000112	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—melanoma	4.01e-05	0.000108	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD44—melanoma	3.99e-05	0.000108	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GNAQ—melanoma	3.99e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—melanoma	3.95e-05	0.000107	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—melanoma	3.93e-05	0.000106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—melanoma	3.89e-05	0.000105	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRAS—melanoma	3.88e-05	0.000105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRAS—melanoma	3.83e-05	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1B1—melanoma	3.83e-05	0.000103	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK3—melanoma	3.72e-05	0.0001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—melanoma	3.67e-05	9.9e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—melanoma	3.63e-05	9.8e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—melanoma	3.62e-05	9.76e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK1—melanoma	3.54e-05	9.55e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—melanoma	3.54e-05	9.54e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—melanoma	3.51e-05	9.48e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—melanoma	3.38e-05	9.13e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRAS—melanoma	3.36e-05	9.07e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—melanoma	3.34e-05	9.02e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—melanoma	3.22e-05	8.68e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—melanoma	3.15e-05	8.5e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—melanoma	3.07e-05	8.28e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—melanoma	2.97e-05	8.01e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—melanoma	2.97e-05	8.01e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PRKCA—melanoma	2.9e-05	7.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ERCC2—melanoma	2.88e-05	7.76e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRAS—melanoma	2.84e-05	7.66e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—melanoma	2.72e-05	7.33e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—melanoma	2.51e-05	6.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—melanoma	2.27e-05	6.13e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARG—melanoma	2.19e-05	5.92e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—melanoma	2e-05	5.39e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—melanoma	1.97e-05	5.32e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—melanoma	1.74e-05	4.7e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—melanoma	1.73e-05	4.65e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—melanoma	1.5e-05	4.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—melanoma	1.06e-05	2.86e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—melanoma	8.67e-06	2.34e-05	CbGpPWpGaD
